Analyst Profile

Followed by 151 followers
.
Mohit Bansal

Mohit Bansal

Wells Fargo
Wall Street Analyst
#1,374 out of 8,164 Wall Street Analysts
#2,754 out of 24,495 experts

Success Rate

55%
69 out of 125 transactions made a profit

Average Return

+8.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying Mohit Bansal's trades since 2018 and holding each position for 1 Year would result in 55.20% of your transactions generating a profit, with an average return of 8.4% per rating.

Stock Rating Distribution

183Ratings
71.04% Buy
25.68% Hold
3.28% Sell
Distribution of Mohit Bansal's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Karuna Therapeutics, Inc.
(KRTX)
Rating:Buy
Date:Jul 23, 2019 - Jul 23, 2020
Return:+366.00%
The most profitable rating made by Mohit Bansal

Mohit Bansal's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
AVXS
AveXis Inc
Jan 26, 2018
Buy
Reiterated
5Ratings
100%
+165.83%
ONCE
Spark Therapeutics
Aug 07, 2018
Buy
Upgraded
2Ratings
100%
+79.80%
Avantor
Jun 11, 2019
Buy
Initiated
$21.00
(-3.71% Downside)
1Ratings
0%
-5.30%
BOLD
Audentes Therapeutics
Dec 03, 2019
Hold
Upgraded
5Ratings
0%
-57.25%
Adaptimmune Therapeutics
Apr 27, 2020
Buy
Reiterated
$5.00
(177.78% Upside)
2Ratings
100%
+145.65%
BioMarin Pharmaceutical
Aug 19, 2020
Hold
Downgraded
$86.00
(-17.06% Downside)
5Ratings
50%
-9.65%
CytomX Therapeutics
Sep 15, 2020
Hold
Reiterated
$8.50
(437.97% Upside)
4Ratings
0.00%
MYOK
MyoKardia
Oct 06, 2020
Hold
Downgraded
5Ratings
75%
+91.88%
ALXN
Alexion Pharmaceuticals
Dec 14, 2020
Buy
Reiterated
9Ratings
75%
+19.31%
Agios Pharma
Dec 23, 2020
Buy
Reiterated
$65.00
(132.72% Upside)
5Ratings
50%
-4.65%
List of latest recommendations made by Mohit Bansal. Click to expand and see Mohit Bansal's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >